AU526207B2 - Amino acid solutions as food for patients with cancer - Google Patents

Amino acid solutions as food for patients with cancer

Info

Publication number
AU526207B2
AU526207B2 AU50368/79A AU5036879A AU526207B2 AU 526207 B2 AU526207 B2 AU 526207B2 AU 50368/79 A AU50368/79 A AU 50368/79A AU 5036879 A AU5036879 A AU 5036879A AU 526207 B2 AU526207 B2 AU 526207B2
Authority
AU
Australia
Prior art keywords
cancer
patients
food
amino acid
acid solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU50368/79A
Other languages
English (en)
Other versions
AU5036879A (en
Inventor
Kohi Ozeki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU5036879A publication Critical patent/AU5036879A/en
Application granted granted Critical
Publication of AU526207B2 publication Critical patent/AU526207B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU50368/79A 1978-09-04 1979-08-29 Amino acid solutions as food for patients with cancer Expired AU526207B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10874978 1978-09-04
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Publications (2)

Publication Number Publication Date
AU5036879A AU5036879A (en) 1980-03-13
AU526207B2 true AU526207B2 (en) 1982-12-23

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50368/79A Expired AU526207B2 (en) 1978-09-04 1979-08-29 Amino acid solutions as food for patients with cancer

Country Status (10)

Country Link
JP (1) JPS5535049A (enrdf_load_html_response)
AU (1) AU526207B2 (enrdf_load_html_response)
CA (1) CA1134275A (enrdf_load_html_response)
CH (1) CH642541A5 (enrdf_load_html_response)
DE (1) DE2935709C2 (enrdf_load_html_response)
FR (1) FR2434622A1 (enrdf_load_html_response)
GB (1) GB2029220B (enrdf_load_html_response)
IT (1) IT1194844B (enrdf_load_html_response)
NL (1) NL190266C (enrdf_load_html_response)
SE (1) SE448679B (enrdf_load_html_response)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58500526A (ja) * 1981-04-17 1983-04-07 アメリカン　ホスピタル　サプライ　コ−ポレ−シヨン 非経口栄養供給のための改良溶液
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
DE3329253A1 (de) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
FR2591893B1 (fr) * 1985-12-19 1988-11-10 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
EP0560989B1 (en) * 1991-10-07 1999-09-01 Otsuka Pharmaceutical Factory, Inc. Enteral preparation for cancer therapy
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
DE4228897A1 (de) * 1992-08-29 1994-03-03 Wella Ag Mittel zur Festigung der Haare auf der Basis von Lignin oder Ligninderivaten sowie Dihydroxypropyllignin
EP0668933B1 (en) * 1992-11-19 2002-10-02 Anticancer, Inc. Use of methioninase as an antitumor agent in anti-methionine chemotherapy
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
RU2125874C1 (ru) * 1994-07-04 1999-02-10 Казанский государственный университет им.В.И.Ульянова-Ленина Композиция аминокислот с микроэлементами, обладающая противоопухолевой и антигипоксической активностью
AU716906B2 (en) * 1996-07-30 2000-03-09 Novartis Nutrition Ag Amino acid composition and use thereof in treating tumor growth and metastasis
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
RU2144821C1 (ru) * 1999-02-16 2000-01-27 Товарищество с ограниченной ответственностью Фирма "ГЛЕС" Противоопухолевое средство
DK1163904T3 (da) * 2000-06-16 2006-08-14 Matthias Dr Med Rath Sammensætning til forebyggelse af glat muskelsygdom, der omfatter ascorbat, arginin og magnesium
EP1195159B1 (en) * 2000-10-09 2006-05-31 Rath, Matthias, Dr. med. Therapeutic combination of ascorbate with lysine and arginine for prevention and treatment of cancer
US6974833B2 (en) 2001-01-16 2005-12-13 Matthias Rath Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
JPWO2003030890A1 (ja) * 2001-10-05 2005-02-10 哲朗 浅尾 免疫系活性化剤
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
EP1734819A1 (en) * 2004-03-19 2006-12-27 Pro-Pharmaceuticals, Inc. Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
HRP20120489T1 (hr) * 2005-07-29 2012-07-31 TIMA@Foundation Pripravak za ublažavanje metabolizma alkohola i za smanjivanje rizika od bolesti uzrokovanih alkoholom
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
WO2007016953A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing alcohol induced liver cancer risk
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
PL2156188T3 (pl) 2007-03-28 2021-11-15 University Of Southern California Indukcja zróżnicowanej odporności na stres i jej zastosowania
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
CA3045883C (en) * 2008-04-24 2022-06-28 University Of Southern California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
KR101919747B1 (ko) * 2011-02-17 2018-11-20 각꼬호우진 구루메 다이가쿠 화학요법제의 항종양 활성 증강제
JP2016117702A (ja) * 2014-12-22 2016-06-30 武輝 山田 ガン細胞の死滅法
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JP7266581B2 (ja) 2017-08-14 2023-04-28 アクセラ・ヘルス・インコーポレイテッド 肝疾患の治療のためのアミノ酸組成物
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT297935B (de) * 1968-05-09 1972-04-10 Astra Ab Verfahren zur Herstellung einer Infusionslösung von essentiellen Aminosäuren zur intravenösen Zufuhr bei urämischen Zuständen
SU423304A3 (enrdf_load_html_response) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2013026C3 (de) * 1970-03-19 1981-01-29 Wagner, Karl-Heinz, Prof. Dr.Med.Habil., 6300 Giessen Mittel zur Behandlung und Verhütung von Leberkrankheiten und muskulärer Insuffizienz
DE2530246A1 (de) * 1975-07-07 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2531204C2 (de) * 1975-07-12 1987-01-22 Fresenius AG, 6380 Bad Homburg L-Aminosäuregemische für die parenterale oder orale Ernährung

Also Published As

Publication number Publication date
JPS6154007B2 (enrdf_load_html_response) 1986-11-20
DE2935709A1 (de) 1980-03-13
IT1194844B (it) 1988-09-28
NL190266B (nl) 1993-08-02
AU5036879A (en) 1980-03-13
NL7906620A (nl) 1980-03-06
GB2029220A (en) 1980-03-19
GB2029220B (en) 1983-03-30
JPS5535049A (en) 1980-03-11
NL190266C (nl) 1994-01-03
DE2935709C2 (de) 1986-02-06
SE448679B (sv) 1987-03-16
CA1134275A (en) 1982-10-26
FR2434622B1 (enrdf_load_html_response) 1983-04-15
FR2434622A1 (fr) 1980-03-28
IT7905216A0 (it) 1979-09-03
SE7907316L (sv) 1980-03-05
CH642541A5 (de) 1984-04-30

Similar Documents

Publication Publication Date Title
AU526207B2 (en) Amino acid solutions as food for patients with cancer
AU530380B2 (en) Amino acid derivatives as antihypertensives
AU508419B2 (en) Phenoxyalkylcarboxylic acid derivatives
AU6412280A (en) Imidazole-5-acetic acid derivatives
AU515455B2 (en) Acid tinplating solution
AU4413779A (en) Modified azulmic acid
AU538584B2 (en) Cinnamic acid derivatives
AU5073079A (en) 5-phenylcarbamoylbarbituric acid compounds
AU531501B2 (en) 3-quinoline-carboxylic acid
AU541322B2 (en) 6-beta-halopenicillanic acid derivatiges
AU526877B2 (en) Phenyl-alkanoic acid derivative
AU518251B2 (en) L-halomethyl amino acid derivatives
AU521126B2 (en) 1-naphthyl-acetic acid derivatives
AU5676780A (en) Benzodioxincarboxylic acid derivatives
AU5863380A (en) Acid derivatives
AU4668179A (en) N,n-dimethyl-0-pyrazolyl-carbamic acid esters
AU533620B2 (en) Pyrrolidinyl-sulfamoylbenzoic acid derivatives
AU537900B2 (en) Dihydronicotinic acid derivatives
AU5135679A (en) Preparing terephthalic acid
AU4575479A (en) 4-halo etianic acid derivatives
AU536508B2 (en) Aziridine-2-carboxylic acid
AU5758980A (en) Clauulanic acid derivatives
AU526380B2 (en) 2-isoxazoline-5-acetic acid derivatives
AU530432B2 (en) Amino acid treatment
AU5210679A (en) O-ethyl-s-n-propyl-dithiophosphoryloxy-acetic acid n-methyl- anilide

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired